EUVIMEDEuropean Health Evidence
Uhr Sources10/10 Journal Tree
Easy Demo

European Health Evidence

The European alternative to PubMed

EUVIMED is the European alternative to PubMed: a central, multilingual research platform for medicine, nursing, life sciences and healthcare. It brings together international and European literature sources, study registries, open-access full texts, citations and retraction notices in one search. Unlike pure bibliographic databases, EUVIMED supports the entire research process – from discovery and appraisal with LIVIA and CLARA to traceable evidence synthesis. European in focus, transparent, interoperable and designed for science and healthcare.

EuropeanMultilingualInteroperableTraceable

EUVIMED BETA

EUVIMED is currently in beta

EUVIMED is under continuous development. Features, data coverage and presentation may change or be temporarily incomplete.

Results are beta

Search results, classifications, summaries and AI-assisted assessments may be incomplete, delayed or incorrect.

Check original sources

Do not use EUVIMED results without verification for diagnosis, treatment or other clinical decisions. Always consult the original source and applicable guidelines.

Errors and feedback help us improve EUVIMED: info@euvimed.com

Lokaler Crossref-Datenbestand · journal-article

Litigation in obstetrics and gynaecology in the UK National Health Service over a 17-year period: An analysis of the trends, costs and causes

Anoushka Umranikar, Abhinav Tiwari, Bhaskar K Somani

Scottish Medical Journal · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Introduction Obstetrics and Gynaecology (O&G) is one of the most litigious medical specialities. This study aimed to analyse the trends and reasons for litigation claims in O&G within the UK National Health Service (NHS) over a 17-year period. Methods Using data requested from NHS Resolution under the Freedom of Information Act 2000, an analysis was carried out which included the total number and rate of litigation claims in O&G, the number of these claims that were successful (settled or closed), the damages paid due to successful claims, and the reasons for successful claims between financial years 2006/07 and 2023/24. Results 29,129 litigation claims were made in the speciality of O&G between 2006/07 and 2023/24. 66.0% (19,239/29,129) were in Obstetrics, and 34.0% (9890/29,129) were in Gynaecology. 60.8% (17,698/29,129) of O&G claims were successful. The rate of claims in Obstetrics increased per 1000 births (1.1 in 2006 to 2.5 in 2023/24) from the start to the end of the study period. The primary causes for successful claims in Obstetrics included failure/delay of treatment (16.5%, 1943/11,806), failure/delay in diagnosis (8.8%, 1042/11,806) and failure to make response to abnormal fetal heart rate (7.9%, 931/11,806). For Gynaecology, the primary causes were failure/delay of treatment (15.2%, 898/5892), intra-operative problems (15.1%, 888/5892) and failure/delay in diagnosis (12.5%, 735/5892). Never events accounted for 9.3% (790/17,698) of successful claims in O&G. Conclusion O&G has become an increasingly litigious speciality over the last two decades. Although delay in treatment or diagnosis accounted for the highest proportion of successful claims, never events accounted for just under 10% of cases. More work can be done to reduce the risk of these adverse events.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Anoushka Umranikar, Abhinav Tiwari, Bhaskar K Somani
Quelle
Scottish Medical Journal
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
0036-9330, 2045-6441
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Anoushka Umranikar, Abhinav Tiwari, Bhaskar K Somani (2026). Litigation in obstetrics and gynaecology in the UK National Health Service over a 17-year period: An analysis of the trends, costs and causes. Scottish Medical Journal. https://doi.org/10.1177/00369330261485383
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1